Gregg W Stone. The Lancet, Early Online Publication, 14 January 2010
Tremendous progress has been achieved over the past decade in the treatment of acute coronary syndromes (ST-segment elevation myocardial infarction [STEMI ] , non-STEMI [NSTEMI ] , and unstable angina).
In STEMI, primary percutaneous coronary intervention compared with fibrinolytic therapy reduces mortality, reinfarction, stroke, infarct size, and recurrent ischaemia. 1 In moderate-risk and high-risk patients with NSTEMI, early angiography followed by revascularisation with either percutaneous coronar ...
Weblink here
Tremendous progress has been achieved over the past decade in the treatment of acute coronary syndromes (ST-segment elevation myocardial infarction [STEMI ] , non-STEMI [NSTEMI ] , and unstable angina).
In STEMI, primary percutaneous coronary intervention compared with fibrinolytic therapy reduces mortality, reinfarction, stroke, infarct size, and recurrent ischaemia. 1 In moderate-risk and high-risk patients with NSTEMI, early angiography followed by revascularisation with either percutaneous coronar ...
Weblink here